Skip to Content
David F. Schneider, MD, MS

Surgical Services

Contact Dr. Schneider

E-mail:
schneiderd@surgery.wisc.edu

Phone:
(608) 263-1387

Mail:
600 HIGHLAND AVE
BX7375 CLINICAL SCIENCE CENTER
MADISON, WI 53792-3284

David F. Schneider, MD, MS

Assistant Professor
Section of Endocrine Surgery
Division of General Surgery

Education

  • MD, Loyola Stritch School of Medicine, Chicago, IL, 2004
  • Research Fellowship in Burn & Shock Trauma, Loyola Medical Center, Chicago, IL, 2008
  • MS in Clinical Research Methods, Department of Preventive Medicine & Epidemiology, Loyola Stritch School of Medicine, 2010
  • General Surgery Residency, Loyola Medical Center, Chicago, IL, 2011
  • Fellowship in Endocrine Surgery, University of Wisconsin School of Medicine and Public Health, 2013

Clinical Specialties

Dr. Schneider is certified by the American Board of Surgery, and he is a member of multiple specialty societies including the American Association of Endocrine Surgeons, the American Thyroid Association, the North American NeuroEndocrine Tumor Society, and the American Association of Clinical Endocrinologists. He specializes in endocrine surgery, treating diseases of the thyroid, parathyroid, and adrenal glands. He utilizes several minimally invasive techniques to treat endocrine disorders (endoscopic thyroidectomy, minimally invasive parathyroidectomy, laparoscopic adrenalectomy, focused exploration for recurrent thyroid cancer).

Dr. Schneider provides a wide range of services including Adrenalectomy, Laparoscopic, Adrenalectomy, Open, Adrenal Surgery, Central Neck Dissection, Endocrine Surgery, Fine Needle Aspiration (FNA), Minimally Invasive Parathyroidectomy, Minimally Invasive Radioguided Parathyroidectomy (MIRP), Modified Radical Neck Dissection, Neck Ultrasound, Parathyroid Surgery, Resection Of Substernal Goiter, Subtotal Parathyroidectomy, Thyroidectomy, Thyroid Lobectomy, Thyroid Surgery, and Total Thyroidectomy.

Research Interests

Dr. Schneider conducts outcomes research in conjunction with the Wisconsin Surgical Outcomes Program (WiSOR). His research program investigates the optimization of cancer care in the United States with a particular interest in endocrine cancers. This work utilizes large national databases which can impact national healthcare and policy initiatives. He also conducts clinical research working on hyperparathyroidism, thyroid cancer, Graves’ Disease, and adrenal disorders.

Recent Publications
  • Is central lymph node dissection necessary for parathyroid carcinoma?
    Hsu KT, Sippel RS, Chen H, Schneider DF
    Surgery 2014 Dec; 156(6):1336-41.
    [PubMed ID: 25456903, PMC ID: 4254726]
    More Information
  • The effect of cinacalcet on intraoperative findings in tertiary hyperparathyroidism patients undergoing parathyroidectomy.
    Somnay YR, Weinlander E, Schneider DF, Sippel RS, Chen H
    Surgery 2014 Dec; 156(6):1308-14.
    [PubMed ID: 25456900, PMC ID: 4254721]
    More Information
  • Clinical and Socioeconomic Factors Influence Treatment Decisions in Graves' Disease.
    Elfenbein DM, Schneider DF, Havlena J, Chen H, Sippel RS
    Ann. Surg. Oncol. 2014 Sep 23.
    [PubMed ID: 25245130]
    More Information
  • Outcomes After Subtotal Parathyroidectomy for Primary Hyperparathyroidism due to Hyperplasia: Significance of Whole vs. Partial Gland Remnant.
    Rajaei MH, Oltmann SC, Schneider DF, Sippel RS, Chen H
    Ann. Surg. Oncol. 2014 Sep 23.
    [PubMed ID: 25245126]
    More Information
  • All Thyroid Ultrasound Evaluations are Not Equal: Sonographers Specialized in Thyroid Cancer Correctly Label Clinical N0 Disease in Well Differentiated Thyroid Cancer.
    Oltmann SC, Schneider DF, Chen H, Sippel RS
    Ann. Surg. Oncol. 2014 Sep 19.
    [PubMed ID: 25234019]
    More Information
  • Preventing Postoperative Hypocalcemia in Patients with Graves Disease: A Prospective Study.
    Oltmann SC, Brekke AV, Schneider DF, Schaefer SC, Chen H, Sippel RS
    Ann. Surg. Oncol. 2014 Sep 12.
    [PubMed ID: 25212835]
    More Information
  • CaPTHUS Scoring Model in Primary Hyperparathyroidism: Can It Eliminate the Need for ioPTH Testing?
    Elfenbein DM, Weber S, Schneider DF, Sippel RS, Chen H
    Ann. Surg. Oncol. 2014 Sep 12.
    [PubMed ID: 25212837]
    More Information
  • Justified Follow-Up: A Final Intraoperative Parathyroid Hormone (ioPTH) Over 40 pg/mL is Associated with an Increased Risk of Persistence and Recurrence in Primary Hyperparathyroidism.
    Rajaei MH, Bentz AM, Schneider DF, Sippel RS, Chen H, Oltmann SC
    Ann. Surg. Oncol. 2014 Sep 6.
    [PubMed ID: 25192677]
    More Information
  • Lymph Node Metastases do not Impact Survival in Follicular Variant Papillary Thyroid Cancer.
    Schneider DF, Elfenbein D, Lloyd RV, Chen H, Sippel RS
    Ann. Surg. Oncol. 2014 Aug 5.
    [PubMed ID: 25092163]
    More Information
  • Novel thyroidectomy difficulty scale correlates with operative times.
    Schneider DF, Mazeh H, Oltmann SC, Chen H, Sippel RS
    World J Surg 2014 Aug; 38(8):1984-9.
    [PubMed ID: 24615607, PMC ID: 4251734]
    More Information

webmaster@surgery.wisc.edu Copyright © 2014 The Board of Regents of the University of Wisconsin System